LOSARTAN/HYDROCHLOROTHIAZIDE THERAPY OF HYPERTENSION WITH KIDNEY DISORDER

氯沙坦/氢氯噻嗪治疗高血压伴肾病

• 批准号: 5224316
• 负责人: BARRY BRENNER
• 金额: --
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/5224316
• 关键词: angiotensin II; cardiovascular disorder chemotherapy; chlorothiazide; clinical research; clinical trials; combination therapy; drug adverse effect; drug screening /evaluation; human subject; human therapy evaluation; inhibitor /antagonist; kidney disorder; kidney function; kidney pharmacology

The purpose of this study is to determine if losartan potassium in combination with hydrochlorothiazide is effective and safe in the treatment of high blood pressure in patients with various degrees of renal impairment (decreased kidney function).

本研究的目的是确定氯沙坦钾是否 与氢氯噻嗪合用是有效且安全的 治疗不同程度的高血压患者 肾功能损害（肾功能下降）。